Rescinnamine
Подписчиков: 0, рейтинг: 0
| Clinical data | |
|---|---|
| Trade names | Moderil, Cinnasil, Anaprel |
| Other names | methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-{[(2E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]oxy}-3,13-diazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-2(10),4(9),5,7-tetraene-19-carboxylate |
| Routes of administration |
By mouth |
| ATC code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| DrugBank |
|
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.042.232 |
| Chemical and physical data | |
| Formula | C35H42N2O9 |
| Molar mass | 634.726 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Rescinnamine, known by the brand names moderil, cinnasil, and anaprel, is an angiotensin-converting enzyme inhibitor used as an antihypertensive drug.
It is a vinca alkaloid obtained from Rauvolfia serpentina and other species of Rauvolfia.
|
ACE inhibitors ("-pril") |
|
|---|---|
|
AIIRAs ("-sartan") |
|
|
Renin inhibitors ("-kiren") |
|
| Dual ACE/NEP inhibitors | |
| Neprilysin inhibitors | |
| |